Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecological laparoscopic surgery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Carmel Medical Center
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Elective gynecologic laparoscopic surgery including unilateral or bilateral salpingo-oopherectomy or ovarian cystectomy.

• The patient is not participating in other medical study at present or in the last 30 days.

• The patient signed on an informed consent.

• Age 18 years and above.

• ASA (American Society of Anesthesiologists) physical status grade 1- 2.

Exclusion Criteria:

• Allergy to Ropivacaine, other local anesthetics or other medications listed in the protocol.

• The patient is participating in other medical experiment at present or in the last 30 days.

• Acute Pelvic Inflammatory Disease.

• Coumadin or Aspirin treatment.

• ASA physical status grade 3-4.

• Age < 18 years.

• Significant arrythmias

• Analgesic treatment for chronic pain